by Rebecca Kneipp | Mar 12, 2024
Everyone in the healthcare field is very aware of the ongoing DME billing schemes. The most recent topic in the news has been the intermittent catheters schemes. Catheters are thin, flexible tubes that play a crucial role in managing various urinary and other medical...
by Rebecca Kneipp | Feb 13, 2024
Medicare lays out clear guidelines for Annual Wellness Visits (AWV), including Personalized Prevention Plan Services (PPPS). There are a number of specific requirements of these visits in order to be eligible for reimbursement. Providers will develop a personalized...
by Rebecca Kneipp | Jan 17, 2024
This article delves into modifier 63, a key piece for dealing with the smallest patients, infants weighing less than 4 kg. Modifier 63 addresses the additional time, complexities, and challenges of treating infants under 4kg or about 8.8 pounds. To put this in...
by Karen Weintraub | Dec 18, 2023
Nuedexta, a drug marketed for Pseudobulbar Affect (PBA), a condition causing uncontrollable laughing or crying, finds itself under a cloud of controversy. According to the manufacturer[1]: “PBA is a medical condition that causes involuntary, sudden, and frequent...
by Rebecca Kneipp | Nov 21, 2023
In this article, we discuss Adderall and its treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) as well concerns expressed by Federal agencies regarding Adderall drug shortages including a range of factors leading to such shortages such as off-label...
